Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial

Trial Profile

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Afatinib (Primary) ; Axitinib (Primary) ; Bosutinib (Primary) ; Cobimetinib (Primary) ; Crizotinib (Primary) ; Dasatinib (Primary) ; Erlotinib (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Olaparib (Primary) ; Palbociclib (Primary) ; Pertuzumab (Primary) ; Sunitinib (Primary) ; Temsirolimus (Primary) ; Trastuzumab (Primary) ; Vemurafenib (Primary)
  • Indications Multiple myeloma; Non-Hodgkin's lymphoma; Solid tumours
  • Focus Therapeutic Use
  • Acronyms CAPTUR
  • Most Recent Events

    • 09 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top